Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid β-peptide

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cellular and Molecular Life Sciences (CMLS)

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00018-003-3274-6PMID 14770296PMCID PMC11138502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blunt cardiac trauma.

  2008cited by this paper
• MRI relaxation fluctuations in acute reperfused hemorrhagic infarction

  2006cited by this paper
• Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SPC

  2005cited by this paper
• Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.

  2003cited by this paper
• Notch and the amyloid precursor protein are cleaved by similar gamma-secretase(s).

  2003cited by this paper
• Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative

  2003cited by this paper
• Reconstitution of γ-secretase activity

  2003cited by this paper
• γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2

  2003cited by this paper
• eHEART: www.heartjnl.com

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Expression of a Human Surfactant Protein C Mutation Associated with Interstitial Lung Disease Disrupts Lung Development in Transgenic Mice*

  2003cited by this paper
• Reconstitution of gamma-secretase activity.

  2003cited by this paper
• Effects of oligomerization and secondary structure on the surface behavior of pulmonary surfactant proteins SP-B and SP-C.

  2003cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Mutations in the surfactant protein C gene associated with interstitial lung disease.

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Charge Attraction and β Propensity Are Necessary for Amyloid Fibril Formation from Tetrapeptides*

  2002cited by this paper
• MR imaging of myocardial haematoma after blunt chest injury

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Pathogenic Effects of Cerebral Amyloid Angiopathy Mutations in the Amyloid β‐Protein Precursor

  2002cited by this paper
• Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells.

  2002cited by this paper
• Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred.

  2002cited by this paper
• A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing.

  2002cited by this paper
• Hydrogen/deuterium exchange and aggregation of a polyvaline and a polyleucine alpha-helix investigated by matrix-assisted laser desorption ionization mass spectrometry.

  2002cited by this paper
• Kinetic Studies of Amyloid β-Protein Fibril Assembly

  2002cited by this paper
• Overexpression of surfactant protein-C mature peptide causes neonatal lethality in transgenic mice.

  2002cited by this paper
• Hydrogen/Deuterium Exchange and Aggregation of a Polyvaline and a Polyleucine α-Helix Investigated by Matrix-assisted Laser Desorption Ionization Mass Spectrometry*

  2002cited by this paper
• Presenilins are not required for Aβ42 production in the early secretory pathway

  2002cited by this paper
• Biosynthesis of Surfactant Protein C (SP-C)

  2002cited by this paper
• Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes.

  2002cited by this paper
• Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis.

  2002cited by this paper
• Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization.

  2002cited by this paper
• Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides.

  2002cited by this paper
• Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

  2002cited by this paper
• Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells

  2002cited by this paper
• Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin*

  2002cited by this paper
• ER-associated degradation in protein quality control and cellular regulation.

  2002cited by this paper
• Metabolic regulation of brain Abeta by neprilysin.

  2001cited by this paper
• The palmitoyl groups of lung surfactant protein C reduce unfolding into a fibrillogenic intermediate.

  2001cited by this paper
• Folding of prion protein to its native alpha-helical conformation is under kinetic control.

  2001cited by this paper
• Amyloid β-Protein Oligomerization

  2001cited by this paper
• Cellular membrane composition defines A beta-lipid interactions.

  2001cited by this paper
• Amyloid fibrils from muscle myoglobin

  2001cited by this paper
• Folding of Prion Protein to Its Native α-Helical Conformation Is under Kinetic Control*

  2001cited by this paper
• Metabolic Regulation of Brain Aβ by Neprilysin

  2001cited by this paper
• Cellular Membrane Composition Defines Aβ-Lipid Interactions*

  2001cited by this paper
• New developments in animal models of Alzheimer’s disease

  2001cited by this paper
• Homodimerization of Amyloid Precursor Protein and Its Implication in the Amyloidogenic Pathway of Alzheimer's Disease*

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• α-1-Antichymotrypsin Promotes β-Sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer's Disease

  2001cited by this paper
• The Intracellular Domain of the β-Amyloid Precursor Protein Is Stabilized by Fe65 and Translocates to the Nucleus in a Notch-like Manner*

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

  2001cited by this paper
• Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.

  2001cited by this paper
• Free energy barrier estimation of unfolding the α‐helical surfactant‐associated polypeptide C

  2001cited by this paper
• Endogenous β-amyloid production in presenilin-deficient embryonic mouse fibroblasts

  2001cited by this paper
• The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis

  2001cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

  2001cited by this paper
• Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

  2001cited by this paper
• Post-translational processing of surfactant protein-C proprotein: targeting motifs in the NH(2)-terminal flanking domain are cleaved in late compartments.

  2001cited by this paper
• Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.

  2001cited by this paper
• Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals.

  2001cited by this paper
• Function of surfactant proteins B and C.

  2001cited by this paper
• Clearing the brain's amyloid cobwebs.

  2001cited by this paper
• A mutation in the surfactant protein C gene associated with familial interstitial lung disease.

  2001cited by this paper
• Secretion of Surfactant Protein C, an Integral Membrane Protein, Requires the N-terminal Propeptide*

  2001cited by this paper
• Progress in transthyretin fibrillogenesis research strengthens the amyloid hypothesis

  2001cited by this paper
• Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• Prediction of Amyloid Fibril-forming Proteins*

  2001cited by this paper
• Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues.

  2001cited by this paper
• The β-Amyloid Precursor Protein and its Derivatives: From Biology to Learning and Memory Processes

  2000cited by this paper
• Modulation of Aβ Deposition in APP Transgenic Mice by an Apolipoprotein E Null Background

  2000cited by this paper
• Review: modulating factors in amyloid-beta fibril formation.

  2000cited by this paper
• Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques.

  2000cited by this paper
• Understanding the sequence determinants of conformational switching using protein design

  2000cited by this paper
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

  2000cited by this paper
• The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation.

  2000cited by this paper
• Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition

  2000cited by this paper
• Mechanisms of Ventricular Arrhythmias Induced by Myocardial Contusion: A High-resolution Mapping Study in Left Ventricular Rabbit Heart

  2000cited by this paper
• Lewy body variant of Alzheimer's disease: α‐synuclein in dystrophic neurites of Aβ plaques

  2000cited by this paper
• Review: Modulating Factors in Amyloid-β Fibril Formation

  2000cited by this paper
• The Transmembrane Aspartates in Presenilin 1 and 2 Are Obligatory for γ-Secretase Activity and Amyloid β-Protein Generation*

  2000cited by this paper
• The Sulfate Moieties of Glycosaminoglycans Are Critical for the Enhancement of β‐Amyloid Protein Fibril Formation

  1999cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Amyloid fibril formation by pulmonary surfactant protein C

  1999cited by this paper
• Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

  1999cited by this paper
• Designing conditions for in vitro formation of amyloid protofilaments and fibrils.

  1999cited by this paper
• Structural requirements for intracellular targeting of SP-C proprotein.

  1999cited by this paper
• Intracellular Accumulation of Insoluble, Newly Synthesized Aβn-42 in Amyloid Precursor Protein-transfected Cells That Have Been Treated with Aβ1–42*

  1999cited by this paper
• Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity

  1999cited by this paper
• Purification and cloning of amyloid precursor protein β-secretase from human brain

  1999cited by this paper
• Identification of a novel aspartic protease (Asp 2) as beta-secretase.

  1999cited by this paper
• Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides.

  1999cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• Clearance of SPC and recombinant SPC in vivo and in vitro

  1998cited by this paper
• Pulmonary surfactant‐associated polypeptide C in a mixed organic solvent transforms from a monomeric α‐helical state into insoluble β‐sheet aggregates

  1998cited by this paper
• Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution.

  1998cited by this paper
• Structure and properties of surfactant protein B.

  1998cited by this paper
• Clearance of SP-C and recombinant SP-C in vivo and in vitro.

  1998cited by this paper
• Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture

  1998cited by this paper
• Circulating cardiac troponin T in myocardial contusion.

  1997cited by this paper

• Cyclin G1 Regulates the Alveolarization in Models of Bronchopulmonary Dysplasia by Inhibiting AT2 Cell Proliferation

  2025cites this paper
• Pulmonary Surfactant: A Mighty Thin Film.

  2023cites this paper
• Exploring protein–protein interactions and oligomerization state of pulmonary surfactant protein C (SP‐C) through FRET and fluorescence self‐quenching

  2023cites this paper
• Surfactant Protein B and C (SP-B and SP-C)

  2021cites this paper
• Alveolar Dynamics and Beyond – The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis

  2020cites this paper
• Restoring pulmonary surfactant membranes and films at the respiratory surface.

  2017cites this paper
• Relaciones estructura-función de la proteína SP-C del surfactante pulmonar: efectos sobre la estructura de membranas y papel del colesterol

  2017cites this paper
• The Effect of Membrane Environment on Surfactant Protein C Stability Studied by Constant-pH Molecular Dynamics

  2015cites this paper
• 1657-1677 Gupta 427

  2014cites this paper
• Zellbiologische Charakterisierung von Surfactant Protein C Mutationen bei Interstitiellen Lungenkrankheiten

  2014influential citation
• Structure, function and deficiency diseases of lung surfactant protein-c

  2014cites this paper
• SFTPC mutations cause SP‐C degradation and aggregate formation without increasing ER stress

  2013cites this paper
• Study of pH-dependent misfolding of surfactant protein C using state-of-the-art molecular modelling techniques

  2011cites this paper
• Characteristics of disorders associated with genetic mutations of surfactant protein C

  2010cites this paper
• Two novel mutations in surfactant protein-C, lung function and obstructive lung disease.

  2010cites this paper
• The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation.

  2010cites this paper
• Towards the treatment of polyglutamine diseases: the modulatory role of protein context.

  2010cites this paper
• The Brichos domain of prosurfactant protein C can hold and fold a transmembrane segment

  2009cites this paper
• Peptide-binding specificity of the prosurfactant protein C Brichos domain analyzed by electrospray ionization mass spectrometry.

  2009cites this paper
• Cholesterol modulates the exposure and orientation of pulmonary surfactant protein SP-C in model surfactant membranes.

  2009cites this paper
• C‐terminal, endoplasmic reticulum‐lumenal domain of prosurfactant protein C – structural features and membrane interactions

  2008cites this paper
• ERdj4 and ERdj5 are required for endoplasmic reticulum-associated protein degradation of misfolded surfactant protein C.

  2008cites this paper
• Synthetic pulmonary surfactant preparations: new developments and future trends.

  2008cites this paper
• Biochemische Analyse bronchoalveolärer Lavagen von Patienten mit pulmonaler Alveolarproteinose

  2008cites this paper
• Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein C.

  2008cites this paper
• AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides

  2007cites this paper
• Protein aggregation as a cause for disease.

  2006cites this paper
• Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung.

  2006cites this paper
• Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C.

  2006cites this paper
• SURFACTANT | Surfactant Proteins B and C (SP-B and SP-C)

  2006cites this paper
• PROCESSING, STABILITY AND INTERACTIONS OF LUNG SURFACTANT PROTEIN C

  2005cites this paper
• Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40.

  2005cites this paper
• Surfactant protein C biosynthesis and its emerging role in conformational lung disease.

  2005cites this paper
• Nonspecific Interstitial Pneumonia, Alveolar Proteinosis, and Abnormal Proprotein Trafficking Resulting from a Spontaneous Mutation in the Surfactant Protein C Gene

  2005cites this paper
• Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer Aβ42 Peptide Relative to Aβ40*

  2005cites this paper
• Lung surfactant gelation induced by epithelial cells exposed to air pollution or oxidative stress.

  2005cites this paper
• The N-terminal propeptide of lung surfactant protein C is necessary for biosynthesis and prevents unfolding of a metastable alpha-helix.

  2004cites this paper
• The N-terminal Propeptide of Lung Surfactant Protein C is Necessary for Biosynthesis and Prevents Unfolding of a Metastable α-Helix

  2004cites this paper
• Fellowships, Grants, & Awards

  2004cites this paper
• Software AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides

  year unknowncites this paper